Eradication of Helicobacter pylori Improves the Healing Rate and Reduces the Relapse Rate of Nonbleeding Ulcers in Patients With Bleeding Peptic Ulcer

American Journal of Gastroenterology

Volumn 98, Issue 10, 2003, Pages 2149-2156

  Arkkila, Perttu E T ^a   Seppälä, Kari ^b   Kosunen, Timo U ^b   Haapiainen, Reijo ^b   Kivilaakso, Eero ^b   Sipponen, Pentti ^b   Mäkinen, Judit ^b   Nuutinen, Hannu ^b   Rautelin, Hilpi ^b   Färkkilä, Martti A ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; METRONIDAZOLE; OMEPRAZOLE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PEPTIC ULCER; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS; RANDOMIZED CONTROLLED TRIAL; RECURRENT PEPTIC ULCER; RISK FACTOR; ULCER HEALING;

EID: 0142183687     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.07682.x     Document Type: Article

References (49)

1. Marshall BJ, Goodwin CS, Warren JR, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988;2:1437-42.
2. Rauws EA, Tytgat GN. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990;335:1233-5.
3. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 1992;116:705-8.
4. Hentschel E, Brandstatter G, Dragosics B, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993;328:308-12.
5. Seppälä K. H. pylori and gastric ulcer disease. In: Hunt RH, Tytgat GNJ, eds. Helicobacter pylori. Basic mechanisms to clinical cure. Dordrecht/Boston/London: Kluwer Academic Publishers, Lancaster, UK 1994:429-36.
6. Sung JJ, Chung SC, Ling TK, et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med 1995;332:139-42.
7. Fries JF, Williams CA, Bloch DA, et al. Nonsteroidal anti-inflammatory drug-associated gastropathy: Incidence and risk factor models. Am J Med 1991;91:213-22.
8. Langman MJ. Epidemiologic evidence on the association between peptic ulceration and antiinflammatory drug use. Gastroenterology 1989;96:640-6.
9. Somerville K, Faulkner G, Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986;1:462-4.
10. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 1991;115:787-96.
11. Hosking SW, Yung MY, Chung SC. Differing prevalence of Helicobacter in bleeding and nonbleeding ulcers. Gastroenterology 1992;102:A85.
12. Reinbach DH, Cruickshank G, McColl KE. Acute perforated duodenal ulcer is not associated with Helicobacter pylori infection. Gut 1993;34:1344-7.
13. Sebastian M, Chandran VP, Elashaal YI, et al. Helicobacter pylori infection in perforated peptic ulcer disease. Br J Surg 1995;82:360-2.
14. Santolaria S, Lanas A, Benito R, et al. Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users. Aliment Pharmacol Ther 1999;13:1511-8.
15. Laine L, Peterson WL. Bleeding peptic ulcer. Engl J Med 1994;331:717-27.
16. Lau JY, Sung JJ, Lee KK, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 2000;343:310-6.
17. Murray WR, Cooper G, Laferla G, et al. Maintenance ranitidine treatment after haemorrhage from a duodenal ulcer. A 3-year study. Scand J Gastroenterol 1988;23:183-7.
18. Jensen DM, Cheng S, Kovacs TO, et al. A controlled study of ranitidine for the prevention of recurrent hemorrhage from duodenal ulcer. N Engl J Med 1994;330:382-6.
19. Seppälä K, Pikkarainen P, Sipponen P, et al. Cure of peptic gastric ulcer associated with eradication of Helicobacter pylori. Finnish Gastric Ulcer Study Group. Gut 1995;36:834-7.
20. Graham DY, Hepps KS, Ramirez FC, et al. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol 1993;28:939-42.
21. Rokkas T, Karameris A, Mavrogeorgis A, et al. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc 1995;41:1-4.
22. Sung JJ, Leung WK, Suen R, et al. One-week antibiotics versus maintenance acid suppression therapy for Helicobacter pylori-associated peptic ulcer bleeding. Dig Dis Sci 1997;42:2524-8.
23. Lai KC, Hui WM, Wong WM, et al. Treatment of Helicobacter pylori in patients with duodenal ulcer hemorrhage-a long term randomized, controlled study. Am J Gastroenterol 2000;95:2225-32.
24. Chan FK, Sung JJ, Suen R, et al. Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomized study. Aliment Pharmacol Ther 1998;12:1201-5.
25. Price AB. The Sydney System: Histological division. J Gastroenterol Hepatol 1991;6:209-22.
26. Kosunen TU, Seppälä K, Sarna S, et al. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet 1992;339:893-5.
27. Rautelin H, Seppälä K, Renkonen OV, et al. Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemother 1992;36:163-6.
28. Dieulafoy G. Exulceration simplex. L'intervention chirurgicale dans la hematemesis foudroyantes consecutives a l'exulceration simple de l'esomac. Bull Acad Med 1898;39:49-84.
29. Katz PO, Salas L. Less frequent causes of upper gastrointestinal bleeding. Gastroenterol Clin North Am 1993;22:875-89.
30. Seppälä K, Kivelä H, Äärimaa M. Acute bleeding in the upper GI tract. The analysis of one hundred consecutive patients (in Finnish). Duodecim 1974;90:1218-27.
31. Labenz J, Borsch G. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection. Am J Gastroenterol 1994;89:1785-8.
32. Santander C, Gravalos RG, Gomez-Cedenilla A, et al. Antimicrobial therapy for Helicobacter pylori infection versus long term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: Prospective nonrandomized trial on 125 patients. Am J Gastroenterol 1996;91:1549-52.
33. Macri G, Milani S, Surrenti E, et al. Eradication of Helicobacter pylori reduces the rate of duodenal ulcer rebleeding: A long term follow-up study. Am J Gastroenterol 1998;93:925-7.
34. Malfertheiner P, Leodolter A, Peitz U. Cure of Helicobacter pylori-associated ulcer disease through eradication. Baillieres Best Pract Res Clin Gastroenterol 2000;14:119-32.
35. Porro GB, Lazzaroni M. The conflicting relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in peptic ulcer bleeding. Scand J Gastroenterol 1999;3:225-7.
36. Ng EK, Lam YH, Sung JJ, et al. Eradication of Helicobacter pylori prevents recurrence of ulcer after simple closure of duodenal ulcer perforation. Randomized controlled trial. Ann Surg 2000;231:153-8.
37. Fry J. Peptic ulcer disease: A profile. Br Med J 1964;2:809.
38. Borland JL Sr, Hancock WR, Borland JL Jr. Recurrent upper gastrointestinal hemorrhage in peptic ulcer. Gastroenterology 1967;52:631-7.
39. Rockall TA, Logan RF, Devlin HB, et al. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. Br Med J 1995;311:222-6.
40. Ruigomez A, Garcia Rodriguez LA, Hasselgren G, et al. Overall mortality among patients surviving an episode of peptic ulcer bleeding. J Epidemiol Commun Health 2000;54:130-3.
41. Leivonen M, Kivilaakso E. Peptic ulcer bleeding today: Risk factors and characteristics of the disease. Scand J Gastroenterol 1991;26:1013-9.
42. Jaspersen D, Koerner T, Schorr W, et al. Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage. Gastrointest Endosc 1995;41:5-7.
43. Chan FK, Chung SC, Suen BY, et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 2001;344:967-73.
44. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996;334:1018-22.
45. Laine L, Marin-Sorensen M, Weinstein WM. Nonsteroidal antiinflammatory drug-associated gastric ulcers do not require Helicobacter pylori for their development. Am J Gastroenterol 1992;87:1398-402.
46. el-Omar E, Penman I, Dorrian CA, et al. Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut 1993;34:1060-5.
47. Moss SF, Calam J. Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: Effect of eradication of Helicobacter pylori. Gut 1993;34:888-92.
48. de Boer WA, Driessen WM, Potters VP, et al. Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori. Am J Gastroenterol 1994;89:1993-7.
49. Seppälä K, Kosunen TU, Nuutinen H, et al. Cure of Helicobacter pylori infection after failed primary treatment: One-center results from 120 patients. Scand J Gastroenterol 2000;35:929-34.